Side effects as predictors of drug response in obsessive-compulsive disorder.

Ackerman, D L; Greenland, S; Bystritsky, A

Ackerman, D L; Greenland, S; Bystritsky, A.

Affiliation

Ackerman DL; Department of Epidemiology, UCLA School of Public Health, Los Angeles, California 90095, USA.

J Clin Psychopharmacol ; 19(5): 459-65, 1999 Oct.

Article in En | MEDLINE | ID: mdl-10505588

Subject(s)

Obsessive-Compulsive Disorder/drug therapy; Selective Serotonin Reuptake Inhibitors/adverse effects; Selective Serotonin Reuptake Inhibitors/therapeutic use; Adolescent; Adult; Anxiety/chemically induced; Clomipramine/administration & dosage; Clomipramine/adverse effects; Clomipramine/therapeutic use; Dose-Response Relationship, Drug; Ejaculation/drug effects; Female; Fluoxetine/administration & dosage; Fluoxetine/adverse effects; Fluoxetine/therapeutic use; Humans; Libido/drug effects; Male; Middle Aged; Obsessive-Compulsive Disorder/psychology; Orgasm/drug effects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors/administration & dosage; Sexual Dysfunction, Physiological/chemically induced; Sleep Initiation and Maintenance Disorders/chemically induced

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Selective Serotonin Reuptake Inhibitors / Obsessive-Compulsive Disorder Type of study: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Psychopharmacol Year: 1999 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links